Promotes gut health

      Improves symptoms of Irritable Bowel Syndrome

      Improves symptoms of Functional Abdominal Pain

●      Improves  “windiness” and bloating

      Reduces stomach irritation and helps to heal gastric ulcers

Many people suffer from a condition called Irritable Bowel Syndrome (IBS). The symptoms of IBS are usually abdominal windiness, bloating, colic and either diarrhoea or constipation.

No one knows what the actual cause of IBS is but research indicates that people suffering from IBS tend to have inflammation in the intestines, abnormal “leakiness” in their intestines as well as irregular patterns of contraction of the intestines.

In children, a condition called Functional Abdominal Pain (FAP) is also common. In this condition children have repeated episodes of abdominal pain without any apparent physical reason.

Both IBS and FAP are very difficult to treat. Clinical studies have indicated that GG probiotic can reduce the symptoms of these two common conditions.

How should  LACTOGG® be taken?

Babies and children:

1 sachet or 1 capsule a day


At least 1 sachet or 1 capsule a day


Bruzzese E et al. Disrupted intestinal microbiota and intestinal inflammation in children with cystic fibrosis and its restoration with Lactobacillus GG: A randomised clinical trial. PLoS One, 2014;9(2):e87796

Commane DM et al. Effects of fermentation products of pro-and prebiotics on trans-epithelial electrical resistance in an in vitro model of the colon. Nutr Cancer 2005:51:102-109

Donato KA et al. Lactobacillus rhamnosus GG attenuates interferon-ɣ and tumor necrosis factor-ɑ-induced barrier dysfunction and pro-inflammatory signalling. Microbiology 2010, 156, 3288–3297

Tao Y et al. Soluble factors from Lactobacillus GG activate MAPKs and induce cytoprotective heat shock proteins in intestinal epithelial cells. Am J Physiol Cell Physiol 2006;290:C1018-30

Yan F et al. Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth. Gastroenterology 2007;132:562-75

Yan F et al. A Lactobacillus rhamnosus GG-derived soluble protein, p40, stimulates ligand release from intestinal epithelial cells to transactivate epidermal growth factor receptor. J Biol Chem 2013;288(42) 30742-51

Hong Kong Special Administrative Region PaediHealth (HK) Ltd. (1286528) 18th Floor, United Centre, 95 Queensway
Hong Kong
Tel: +852 3486 7233     Fax: +852 3486 3723
China Guangzhou Synthgensys Biotechnology Co. Ltd. Unit 501-1, No. 7, Spiral 4 Road, Guangzhou International Bioisland, P R China Tel: +0757 26616888     Fax: +0757 26382288 Brunei Am Prolife Company (P20017787) P.O. Box 31, Jalan Gadong
BE3919, Brunei Darulssalam
Tel: +673 7335566
Singapore ProbioCare Pte. Ltd. (201603757R) 32 Ean Kiam Place
Singapore 429119
Tel: +65 6255 5592     Fax: +65 6255 5563
Malaysia ProbioCare Sdn. Bhd. (1124987-P) 122 Jalan Ipoh
51200 Kuala Lumpur
Malaysia Tel: +603 2011 1223     Fax: +603 2094 7723

Thailand Paedicare (Thailand) Co. Ltd 973 President Tower, Level 14
Unit D and E (1423) Ploenchit Road, Lumpini,
Pathumwan, Bangkok 10330, Thailand
Tel: +66 99 2828338
FOLLOW US Brochures Privacy Policy Glossary
Copyright 2017-2022 Guangzhou Synthgensys Biotechnology Co.Ltd.